Bebawy, Mary - University of Technology Sydney - Graduate School of Health， Master of Pharmacy

个人简介

A/Prof Mary Bebawy has a BSc (Hons) UNSW, PhD (Pharmacy) USYD. She specialises in the role and regulation of the xenobiotic cascade in drug disposition and in cancer multidrug resistance (MDR). In addition to 16 years in academic research and teaching positions, she has spent 2 years in industry as a Post doctoral Preclinical Drug Development Scientist with Johnson and Johnson, Research, Sydney (2002-04) and one year as Associate Dean (Undergraduate) at The Pharmacy Faculty, USyd (2004-05), a position for which she was nominated. She has consulted to academia and industry on assay development, drug discovery and cancer resistance mechanisms. She has recently been appointed (by invitation) to the position of Associate Professor at the University of Technology, Sydney with the Graduate School of Pharmacy. Associate Professor Mary Bebawy is also the inaugural Responsible Academic Officer for Research and Innovation for the Graduate School of Health at UTS. Her responsibilities also include the Research and Innovation portfolio for the Graduate School of Health.

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Gong, J., Luk, F., Jaiswal, R. & Bebawy, M. 2014, 'Microparticles derived from drug-resistant cells regulate miR-503 and PYK2 to promote migration and invasion in breast cancer', AACR Precision Medicine Series: Drug Sensitivity and Resistance: Improving Cancer Therapy, Clinical Cancer Research, Orlando, FL View/Download from: UTS OPUS or Publisher's site Bebawy, M., Lu, J.-.F., Pokharel, D. & Luk, F. 2015, 'Functional translation of total RNA packaged in microparticles shed from multidrug resistant cancer cells', Clin Cancer Res February 15, 2015 21; B19, AACR Precision Medicine Series: Drug Sensitivity and Resistance: Improving Cancer Therapy; June 18-21, 2014; Orlando, FL View/Download from: UTS OPUS or Publisher's sit Krishnan, R.S., Luk, F., Brown, R.-.D., Kwan, Y.-.L. & Bebawy, M. 2015, 'A novel personalized therapeutic management in multiple myeloma', Clin Cancer Res February 15, 2015 21; B52, AACR Precision Medicine Series: Drug Sensitivity and Resistance: Improving Cancer Therapy; June 18-21, 2014; Orlando, FL, AACR, Orlando, USA, pp. B52-B52 View/Download from: UTS OPUS or Publisher's site Krishnan, S.R., Bebawy, M., Luk, F., Brown, R.D. & Kwan, Y.L. 2015, 'Multiple myeloma: A novel tailor-made therapeutic management.', CLINICAL CANCER RESEARCH View/Download from: UTS OPUS or Publisher's sit Rajeev Krishnan, S., Bebawy, M., Brown, R.D., Luk, F. & Kwan, Y. 2015, 'Microparticles as novel prognostic markers in multiple myeloma', Cancer Research, AACR 106th Annual Meeting 2015, American Association for Cancer Research, Philadelphia, USA, pp. 5306-5306 View/Download from: Publisher's site Pozzoli, M., Sonvico, F., Ong, H.X., Traini, D., Bebawy, M. & Young, P. 2014, 'Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa', Respiratory Drug Delivery 2014, Virginia Commonwealth University, Fajardo, Puerto Rico, pp. 739-742 View/Download from: UTS OPU Lee, W., Ong, H., Loo, J., Traini, D., Young, P.M., Luk, F., Bebawy, M. & Rohanizadeh, R. 2013, 'Formulation of curcumin nanoparticles for lung cancer therapy', Drug Delivery to the Lungs, Aerosol Society, Edinburgh, pp. 165-168 Haghi, M., Traini, D., Bebawy, M. & Young, P. 2013, 'Uptake of Salmeterol Xinafoate and Fluticasone Propionate from Single and Combination Dry Powder Inhalers After Deposition on Calu-3 Respiratory Epithelia.', Respiratory Drug Delivery Europe 2013, Respiratory Drug Delivery, Berlin, Germany, pp. 445-448 Bebway, M., Jaiswal, R., Gong, J. & Grau, G. 2013, 'Treatment of Cancer Drug Resistance: microparticle-mediatedresistance', Proceedings of conference on Mechanism-Based Development of Natural Products for Human Health, Journal of Pharmacy & Pharmaceutical Sciences, pp. 125-176 Ong, H.X., Cipolla, D.C., Gonda, I., Traini, D., Bebawy, M., Agus, H. & Young, P.M. 2012, 'Inhaled Liposomal Ciprofloxacin Nanoparticles Control the Release of Antibiotic at the Bronchial Epithelia', Respiratory Drug Delivery Proceedings Vol 3, Respiratory Drug Delivery 2012, Virginia Commonwealth University, Pheonix, USA, pp. 527-530 View/Download from: UTS OPUS or Publisher's sit Haghi, M., Traini, D., Bebawy, M. & Young, P. 2011, 'Comparison of albuterol sulphate and base dry powder particulate deposition using the Calu-3 lung epithelial model', RDD Europe 2011, Respiratory Drug Delivery Europe 2011, Virginia Commonwealth University, Germany, pp. 519-522 View/Download from: UTS OPUS Ong, H.X., Traini, D., Bebawy, M. & Young, P. 2011, 'Cellular release profiling of controlled release dry powder pulmonary formulation', RDD Europe 2011, Respiratory Drug Delivery Europe 2011, Virginia Commonwealth University, Germany, pp. 1-4 View/Download from: UTS OPUS Haghi, M., Young, P., Traini, D. & Bebawy, M. 2010, 'Characterization of P-gp Expression and Function vs. Time and Passage in the Calu-3 Air-Interface Model for Drug Delivery to the Lung', Proceedings of Respiratory Drug Delivery 2010, Respiratory Drug Delivery 2010, Davis Healthcare Int', Orlando, Florida, pp. 875-878 View/Download from: UTS OPUS Bebawy, M., Karantanis, E., Howes, L. & Morris, D.L. 1993, 'Effects of taxotere in combination with lipiodol on C146 in vitro', Effects of taxotere in combination with lipiodol on C146 in vitro, Queensland Institute Medical Research, Australian and New Zealand Journal of Surgery, Brisbane, pp. 363-363.